Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis

BACKGROUND: The number of biological DMARDs (bDMARDs) used in elderly patients with rheumatoid arthritis (RA) has increased in recent years. We aimed to compare the drug retention rates and safety of abatacept (ABT) and tocilizumab (TCZ) in elderly patients with RA. METHODS: A total 125 elderly pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Temmoku, Jumpei, Miyata, Masayuki, Suzuki, Eiji, Sumichika, Yuya, Saito, Kenji, Yoshida, Shuhei, Matsumoto, Haruki, Fujita, Yuya, Matsuoka, Naoki, Asano, Tomoyuki, Sato, Shuzo, Watanabe, Hiroshi, Migita, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484651/
https://www.ncbi.nlm.nih.gov/pubmed/36121851
http://dx.doi.org/10.1371/journal.pone.0274775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484651/
https://www.ncbi.nlm.nih.gov/pubmed/36121851
http://dx.doi.org/10.1371/journal.pone.0274775

Ejemplares similares